Definium Therapeutics, Inc. - Common Shares – Cashflow (NASDAQ:DFTX)

Financials

Mittelzufluss aus laufender Geschäftstätigkeit -45.82 M-50.14 M-64.36 M-79.13 M-131.56 M -144.77 M Mittelzufluss aus Investitionstätigkeit -297 K-297 K——-151.61 M 52.85 M Zahlungsströme aus der Finanzierungstätigkeit 98.82 M59.05 M21.85 M253.2 M267.27 M 271.58 M Freier Cashflow -45.82 M-50.14 M-64.36 M-79.13 M-131.56 M -144.77 M

Definium Therapeutics, Inc. - Common Shares

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.